Medivation: Maker of XTANDI

There are a lot of unmet areas in medicine, that until now, are still waiting for innovations and development to come up with novel therapeutics. The area of oncology is one of these areas that has a huge need for treatment.

Medivation is one of the American biopharmaceutical companies that has taken on the challenge of discovering, developing and studying novel therapeutics to treat serious diseases like breast and prostate cancer. There is a very limited option for treatment for these serious diseases and the company is in the business rapidly developing a promising cure for these maladies. In partnership with Astellas, the company was given the approval from the Food and Drug Administration to start marketing their XTANDI (enzalutamide) capsules to treat patients with metastatic castration-resistant prostate cancer.

Headquartered in San Francisco, California, Medivation continues to explore other means of treating cancer. It partners with other pharmaceutical companies to hasten the development of their drug candidates.